fr   en
Acquisitions
Select a company :
Choose date:
«      1   |   2   |   3   |   4   |   5   |   6   |   7   |   8   |   9   |   10      »      
Date Acquiring pharma company Acquired biotech company Amount Terms / other
2008-07-25 Sanofi-Aventis (France) Acambis (UK) £276 million (€350 million) See details
2008-07-23 Roche (Switzerland) Arius Research (Canada) CAN$ 191 millions (€ 122 million) See details
2008-07-22 Roche (Switzerland) Mirus Bio Corporation (USA) $ 125 million (€ 84.5 million) See details
2008-07-10 Novartis (Switzerland) Speedel (Switzerland) CHF 907 million ($ 880 million) See details
2008-07-03 Shire (GB) Jerini (Germany) €328 million See details
2008-06-17 Boehringer Ingelheim (Germany) Actimis Pharmaceuticals (USA) US$ 515 million. See details
2008-06-09 Sygnis Pharma (Germany) Amnestix (USA) €4 million in cash and shares See details
2008-06-05 Ipsen (France) Tercica (USA) $ 404 million (€ 262.5 million) See details
2008-06-05 Ipsen (France) Vernalis Pharmaceuticals (USA - US subsidiary of Vernalis-UK) $12.5 million (€8.1 million1). See details
2008-06-04 Novartis (Switzerland) Protez Pharmaceuticals (USA) $100 million
See details
2008-05-27 Lonza (Switzerland) Amaxa (Germany, USA) Financial details were not disclosed. See details
2008-05-21 Daiichi Sankyo (Japan) U3 Pharma AG (Germany) € 150 million ($ 235 million) See details
2008-05-16 Antisoma (GB) Xanthus Pharmaceuticals (USA) GBP 26.8 million ($ 52.2 million, € 33.6 million) See details
2008-05-12 Intercell (Austria) Iomai (USA) € 122 million ($ 189 million) See details
2008-04-15 Roche (Switzerland) Piramed (UK) US$ 175 million See details
«      1   |   2   |   3   |   4   |   5   |   6   |   7   |   8   |   9   |   10      »